25 related articles for article (PubMed ID: 38509769)
1. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD).
Zeng A; Yin Y; Xu Z; Abuduwayiti A; Yang F; Shaik MS; Wang C; Chen K; Wang C; Fang X; Dai J
BMC Cancer; 2024 Mar; 24(1):396. PubMed ID: 38553708
[TBL] [Abstract][Full Text] [Related]
3. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
[TBL] [Abstract][Full Text] [Related]
4. Efficient 5-OP-RU-Induced Enrichment of Mucosa-Associated Invariant T Cells in the Murine Lung Does Not Enhance Control of Aerosol Mycobacterium tuberculosis Infection.
Vorkas CK; Levy O; Skular M; Li K; Aubé J; Glickman MS
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077620
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
Shi L; Lu J; Zhong D; Song M; Liu J; You W; Li WH; Lin L; Shi D; Chen Y
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657812
[TBL] [Abstract][Full Text] [Related]
6. MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD-associated NSCLC.
Yin Y; Zeng A; Abuduwayiti A; Xu Z; Chen K; Wang C; Fang X; Wang J; Jiang G; Dai J
Cancer Med; 2024 Mar; 13(6):e7112. PubMed ID: 38509769
[TBL] [Abstract][Full Text] [Related]
7. Chemical insights into the search for MAIT cells activators.
Veerapen N; Hobrath J; Besra AK; Besra GS
Mol Immunol; 2021 Jan; 129():114-120. PubMed ID: 33293098
[TBL] [Abstract][Full Text] [Related]
8. Mucosal-associated invariant T cells for cancer immunotherapy.
Li YR; Zhou K; Wilson M; Kramer A; Zhu Y; Dawson N; Yang L
Mol Ther; 2023 Mar; 31(3):631-646. PubMed ID: 36463401
[TBL] [Abstract][Full Text] [Related]
9. Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential.
Yigit M; Basoglu OF; Unutmaz D
Front Immunol; 2024; 15():1369236. PubMed ID: 38545100
[TBL] [Abstract][Full Text] [Related]
10. MAIT cells in bacterial infectious diseases: heroes, villains, or both?
Wu S; Yang X; Lou Y; Xiao X
Clin Exp Immunol; 2023 Dec; 214(2):144-153. PubMed ID: 37624404
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
Riondino S; Rosenfeld R; Formica V; Morelli C; Parisi G; Torino F; Mariotti S; Roselli M
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610929
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
